Arthritis and Rheumatology

2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases 2023

American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5.  75:E1-E16. 2023

Management of Orofacial Manifestations of Juvenile Idiopathic Arthritis: Interdisciplinary Consensus-Based Recommendations.  75:4-14. 2023

Interactions Between Genetic Risk and Diet Influencing Risk of Incident Female Gout: Discovery and Replication Analysis of Four Prospective Cohorts. 2022

Amplification of inflammation by lubricin deficiency implicated in incident, erosive gout independent of hyperuricemia. 2022

Heavy Chain Constant Region Usage in Antibodies to Peptidylarginine Deiminase 4 as a Marker of Disease Subsets in Rheumatoid Arthritis.  74:1746-1754. 2022

Recombinant Zoster Vaccine Uptake and Risk of Flares Among Older Adults With Immune-Mediated Inflammatory Diseases in the US.  74:1833-1841. 2022

Association of Gout Polygenic Risk Score with Age at Disease Onset and Tophaceous Disease in European and Polynesian Men with Gout. 2022

Is Rheumatoid Arthritis a Causal Factor in Cardiovascular Disease?.  74:1612-1614. 2022

2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.  74:1464-1473. 2022

Evaluation of the Relationship Between Serum Urate Levels, Clinical Manifestations of Gout, and Death From Cardiovascular Causes in Patients Receiving Febuxostat or Allopurinol in an Outcomes Trial.  74:1593-1601. 2022

COVID-19 vaccine uptake and vaccine hesitancy in rheumatic disease patients receiving immunomodulatory therapies in community practice settings.  74:1091-1092. 2022

American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4.  74:21-e36. 2022

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging.  74:570-585. 2022

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis.  74:553-569. 2022

Host Genetics But Not Commensal Microbiota Determines the Initial Development of Systemic Autoimmune Disease in BXD2 Mice.  74:634-640. 2022

The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids.  74:604-611. 2022

Activated Peripheral Blood B Cells in Rheumatoid Arthritis and Their Relationship to Anti–Tumor Necrosis Factor Treatment and Response: A Randomized Clinical Trial of the Effects of Anti–Tumor Necrosis Factor on B Cells.  74:200-211. 2022

International Consensus for the Dosing of Corticosteroids in Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis.  74:263-273. 2022

Progression of Knee Osteoarthritis With Use of Intraarticular Glucocorticoids Versus Hyaluronic Acid.  74:223-226. 2022

A Randomized, Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings 2022

Global Rheumatology Research: Frontiers, Challenges, and Opportunities.  74:1-4. 2022

Supporting International Medical Graduates in Rheumatology: A Call to Action 2022

Assessing the Causal Relationships Between Insulin Resistance and Hyperuricemia and Gout Using Bidirectional Mendelian Randomization.  73:2096-2104. 2021

American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3.  73:e60-e75. 2021

Improved Disease Course Associated With Early Initiation of Biologics in Polyarticular Juvenile Idiopathic Arthritis: Trajectory Analysis of a Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans Study.  73:1910-1920. 2021

Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans.  73:1898-1909. 2021

Elevated Urate Levels Do Not Alter Bone Turnover Markers: Randomized Controlled Trial of Inosine Supplementation in Postmenopausal Women.  73:1758-1764. 2021

Reply.  73:1769-1770. 2021

Reply.  73:1771-1772. 2021

Serum Metabolomics Identifies Dysregulated Pathways and Potential Metabolic Biomarkers for Hyperuricemia and Gout.  73:1738-1748. 2021

A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout Flares.  73:1533-1542. 2021

American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2..  73:e30-e45. 2021

Effect of Serum Urate Lowering With Allopurinol on Blood Pressure in Young Adults: A Randomized, Controlled, Crossover Trial.  73:1514-1522. 2021

Reducing Immunogenicity of Pegloticase With Concomitant Use of Mycophenolate Mofetil in Patients With Refractory Gout: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.  73:1523-1532. 2021

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.  73:1108-1123. 2021

American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1.  73:1093-1107. 2021

Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission.  73:759-768. 2021

Long-Term Safety and Efficacy of Anifrolumab in Adults With Systemic Lupus Erythematosus: Results of a Phase II Open-Label Extension Study.  73:816-825. 2021

Hospitalized Infections in Lupus: A Nationwide Study of Types of Infections, Time Trends, Health Care Utilization, and In-Hospital Mortality.  73:617-630. 2021

Association of Agricultural, Occupational, and Military Inhalants With Autoantibodies and Disease Features in US Veterans With Rheumatoid Arthritis.  73:392-400. 2021

Reply.  73:548-549. 2021

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3.  73:e1-e12. 2021

Anti-Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis but Are Rarely Present in Juvenile Myositis 2021

Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.  73:36-47. 2021

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.  73:121-131. 2021

New Medications Are Needed for Children With Juvenile Idiopathic Arthritis.  72:1945-1951. 2020

Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort.  72:1734-1740. 2020

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 2.  72:e1-e12. 2020

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1.  72:1241-1251. 2020

Association of Visceral Adiposity With Pain but Not Structural Osteoarthritis.  72:1103-1110. 2020

Do Serum Urate–Associated Genetic Variants Differentially Contribute to Gout Risk According to Body Mass Index? Analysis of the UK Biobank.  72:1184-1191. 2020

On the Alert for Cytokine Storm: Immunopathology in COVID-19.  72:1059-1063. 2020

2020 American College of Rheumatology Guideline for the Management of Gout.  72:879-895. 2020

Reply.  72:1040-1041. 2020

Using Cumulative Load to Explain How Body Mass Index and Daily Walking Relate to Worsening Knee Cartilage Damage Over Two Years: The MOST Study.  72:957-965. 2020

Differential DNA Methylation of Networked Signaling, Transcriptional, Innate and Adaptive Immunity, and Osteoclastogenesis Genes and Pathways in Gout.  72:802-814. 2020

2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.  72:529-556. 2020

Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.  72:658-666. 2020

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.  72:220-233. 2020

Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis.  72:326-334. 2020

Georgia Abortion Law and Our Commitment to Patients.  72:377-378. 2020

Population-Specific Patterns of Epigenetic Defects in the B Cell Lineage in Patients With Systemic Lupus Erythematosus.  72:282-291. 2020

Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.  72:67-77. 2020

Toward Accelerated Authorization and Access to New Medicines for Juvenile Idiopathic Arthritis.  71:1976-1984. 2019

2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.  71:1599-1613. 2019

Overrepresentation of Elderly Subjects in a Population-Based Study of Antiphospholipid Syndrome: Comment on the Article by Duarte-García et al.  71:1768-1769. 2019

Reply.  71:1771-1772. 2019

Reply..  71:1771-1772. 2019

Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus.  71:1297-1307. 2019

Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four–Month Randomized, Double-Blind, Double-Dummy Trial.  71:1174-1184. 2019

Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus.  71:1125-1134. 2019

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis.  71:864-877. 2019

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.  71:846-863. 2019

Beyond Autoantibodies: Biologic Roles of Human Autoreactive B Cells in Rheumatoid Arthritis Revealed by RNA-Sequencing.  71:529-541. 2019

Pain Susceptibility Phenotypes in Those Free of Knee Pain With or at Risk of Knee Osteoarthritis: The Multicenter Osteoarthritis Study.  71:542-549. 2019

Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti–Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.  71:451-459. 2019

Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.  71:281-289. 2019

Risk of Knee Osteoarthritis With Obesity, Sarcopenic Obesity, and Sarcopenia.  71:232-237. 2019

Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo-Controlled Study.  71:143-153. 2019

Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.  71:5-32. 2019

Is Low Disease Activity Sufficient as a Target in Systemic Lupus Erythematosus? Comment on the Article by Petri et al.  70:2098-2099. 2018

Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis.  70:2077-2086. 2018

Brief Report: Leg Length Inequality and Hip Osteoarthritis in the Multicenter Osteoarthritis Study and the Osteoarthritis Initiative.  70:1572-1576. 2018

Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans.  70:1654-1660. 2018

Serious Infections in Rheumatoid Arthritis Offspring Exposed to Tumor Necrosis Factor Inhibitors: A Cohort Study.  70:1565-1571. 2018

Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.  70:1508-1518. 2018

Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study.  70:1144-1154. 2018

Brief Report: Novel UNC13D Intronic Variant Disrupting an NF-κB Enhancer in a Patient With Recurrent Macrophage Activation Syndrome and Systemic Juvenile Idiopathic Arthritis.  70:963-970. 2018

Editorial: STATus of STAT3 in Psoriatic Arthritis.  70:801-804. 2018

Transcriptional Profiling of Synovial Macrophages Using Minimally Invasive Ultrasound-Guided Synovial Biopsies in Rheumatoid Arthritis.  70:841-854. 2018

Reply.  70:795-796. 2018

High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti–Tumor Necrosis Factor Therapy.  70:594-605. 2018

Brief Report: Validation of a Definition of Flare in Patients With Established Gout.  70:462-467. 2018

The Science Behind Biosimilars: Entering a New Era of Biologic Therapy.  70:334-344. 2018

Reply.  70:320. 2018

2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups.  69:2271-2282. 2017

Effects of Febuxostat in Early Gout: A Randomized, Double-Blind, Placebo-Controlled Study.  69:2386-2395. 2017

Herpes Zoster as a Risk Factor for Incident Giant Cell Arteritis.  69:2351-2358. 2017

Response to the American College of Physicians Osteoporosis Guideline, 2017 Update.  69:2097-2101. 2017

Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy.  69:1960-1968. 2017

Changing Trends in Opioid Use Among Patients With Rheumatoid Arthritis in the United States.  69:1733-1740. 2017

2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.  69:1538-1551. 2017

Population-Specific Resequencing Associates the ATP-Binding Cassette Subfamily C Member 4 Gene With Gout in New Zealand Māori and Pacific Men.  69:1461-1469. 2017

Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis.  69:1054-1066. 2017

Reply.  69:1122. 2017

Reanalysis of the Multi-Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic-Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al.  69:863-865. 2017

Brief Report: Partial- and Full-Thickness Focal Cartilage Defects Contribute Equally to Development of New Cartilage Damage in Knee Osteoarthritis: The Multicenter Osteoarthritis Study.  69:560-564. 2017

Coronary Artery Calcification and Rheumatoid Arthritis: Lack of Relationship to Risk Alleles for Coronary Artery Disease in the General Population.  69:529-541. 2017

Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.  69:362-375. 2017

Genome-Wide Association Study of Radiographic Knee Osteoarthritis in North American Caucasians.  69:343-351. 2017

Herpes Zoster and the Risk of Stroke in Patients With Autoimmune Diseases.  69:439-446. 2017

Multiple Nonspecific Sites of Joint Pain Outside the Knees Develop in Persons With Knee Pain.  69:335-342. 2017

Improvement of High-Density Lipoprotein Function in Patients With Early Rheumatoid Arthritis Treated With Methotrexate Monotherapy or Combination Therapies in a Randomized Controlled Trial.  69:46-57. 2017

Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study).  69:203-212. 2017

The Association of Vibratory Perception and Muscle Strength With the Incidence and Worsening of Knee Instability: The Multicenter Osteoarthritis Study.  69:94-102. 2017

Brief Report: Risk of Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologic Treatments.  68:2612-2617. 2016

Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study.  68:2403-2411. 2016

Reply.  68:2564. 2016

Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies.  68:2338-2344. 2016

Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein–Enriched Serum in Rheumatoid Arthritis.  68:2099-2105. 2016

Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination.  68:2328-2337. 2016

Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy–Induced Osteoporosis Treated With Alendronate or Teriparatide.  68:2122-2128. 2016

A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach.  68:1932-1944. 2016

Impact of Febuxostat on Renal Function in Gout Patients With Moderate-to-Severe Renal Impairment.  68:2035-2043. 2016

Frequency of Axial Spondyloarthritis Diagnosis Among Patients Seen by US Rheumatologists for Evaluation of Chronic Back Pain.  68:1669-1676. 2016

Identification of IRX1 as a Risk Locus for Rheumatoid Factor Positivity in Rheumatoid Arthritis in a Genome-Wide Association Study.  68:1384-1391. 2016

Regulation of Effector Treg Cells in Murine Lupus.  68:1454-1466. 2016

Identification of a Systemic Lupus Erythematosus Risk Locus Spanning ATG16L2, FCHSD2, and P2RY2 in Koreans.  68:1197-1209. 2016

Reply.  68:1316-1318. 2016

X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome.  68:1290-1300. 2016

Genome-Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture.  68:932-943. 2016

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.  68:566-576. 2016

Association of Joint Inflammation with Pain Sensitization in Knee Osteoarthritis: The Multicenter Osteoarthritis Study.  68:654-661. 2016

Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset with Disease Course in Juvenile Myositis.  68:761-768. 2016

Association of Triple Therapy with Improvement in Cholesterol Profiles over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial.  68:577-586. 2016

Risk Factors for Targeted Fungal and Mycobacterial Infections in Patients Taking Tumor Necrosis Factor Inhibitors.  68:597-603. 2016

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.  68:1-26. 2016

Comparative Risk of Hospitalized Infection Associated with Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare.  68:56-66. 2016

Editorial: A Novel Genetic Association with Systemic Sclerosis: The Utility of Whole-Exome Sequencing in Autoimmune Disease.  68:27-30. 2016

Risk of Subsequent Infection among Patients Receiving Tumor Necrosis Factor Inhibitors and Other Disease-Modifying Antirheumatic Drugs.  68:67-76. 2016

A randomized trial comparing disease activity measures for the assessment and prediction of response in rheumatoid arthritis patients initiating certolizumab pegol.  67:3104-3112. 2015

Gout is a chronic inflammatory disease in which high levels of interleukin-8 (CXCL8), myeloid-related protein 8/myeloid-related protein 14 complex, and an altered proteome are associated with diabetes mellitus and cardiovascular disease.  67:3303-3313. 2015

Patterns of coexisting lesions detected on magnetic resonance imaging and relationship to incident knee osteoarthritis: The multicenter osteoarthritis study.  67:3158-3165. 2015

2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative.  67:2557-2568. 2015

The W620 polymorphism in PTPN22 disrupts its interaction with peptidylarginine deiminase type 4 and enhances citrullination and netosis.  67:2323-2334. 2015

Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: A consortium of rheumatology researchers of North America registry study.  67:1995-2003. 2015

Editorial: The road traveled: Genomics and biomarkers in antineutrophil cytoplasmic antibody-associated vasculitis.  67:1700-1702. 2015

Mood disorders in systemic lupus erythematosus: Results from an international inception cohort study.  67:1837-1847. 2015

Randomized, double-blind, placebo-controlled trial of the effect of vitamin D3 on the interferon signature in patients with systemic lupus erythematosus.  67:1848-1857. 2015

Disease activity in rheumatoid arthritis and the risk of cardiovascular events.  67:1449-1455. 2015

Risk of hospitalized infection among rheumatoid arthritis patients concurrently treated with a biologic agent and denosumab.  67:1456-1464. 2015

Brief report: Expression of interferon-γ receptor genes in peripheral blood mononuclear cells is associated with rheumatoid arthritis and its radiographic severity in african americans.  67:1165-1170. 2015

Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors.  67:1062-1073. 2015

Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis.  67:645-655. 2015

Racial/ethnic variation in all-cause mortality among United States medicaid recipients with systemic lupus erythematosus: A Hispanic and asian paradox.  67:752-760. 2015

HLA-DRB1-associated rheumatoid arthritis risk at multiple levels in African Americans: Hierarchical classification systems, amino acid positions, and residues.  66:3274-3282. 2014

Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A multinational, multicenter study of 362 patients.  66:3160-3169. 2014

Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.  66:2871-2880. 2014

Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells..  66:2558-2569. 2014

Arthroplasty outcomes are improving, but why isn't my patient with rheumatoid arthritis doing as well?.  66:250-253. 2014

Brief report: A polymorphism in TLR2 is associated with arterial thrombosis in a multiethnic population of patients with systemic lupus erythematosus.  66:1882-1887. 2014

CTLA-4Ig-induced T cell anergy promotes Wnt-10b production and bone formation in a mouse model.  66:990-999. 2014

Determinants of mortality among postmenopausal women in the women's health initiative who report rheumatoid arthritis.  66:497-507. 2014

End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.  66:390-396. 2014

Erratum: Incorrect values for intractable and cluster headaches at enrollment shown in figure 1 and incorrect prevalence of headache at ten years in text of the article by hanly et al (Arthritis and Rheumatology (2013)).  66:1671. 2014

Fcγ receptor IIIa single-nucleotide polymorphisms and haplotypes affect human IgG binding and are associated with lupus nephritis in African Americans.  66:1291-1299. 2014

Inhibition of fucosylation reshapes inflammatory macrophages and suppresses type II collagen-induced arthritis.  66:2368-2379. 2014

Interleukin-21 promotes germinal center reaction by skewing the follicular regulatory T cell to follicular helper T cell balance in autoimmune BXD2 mice.  66:2601-2612. 2014

Myeloid-related proteins 8 and 14 contribute to monosodium urate monohydrate crystal-induced inflammation in gout.  66:1327-1339. 2014

Periodontitis and porphyromonas gingivalis in patients with rheumatoid arthritis.  66:1090-1100. 2014

Racial and ethnic differences in older adults with knee osteoarthritis.  66:1800-1810. 2014